Skip to content
NK Cells v5

Cell Health & Apoptosis Assay Services

Multiplexed assays to address complex biology.

Overview

Evaluating the impact of drug candidates on cell proliferation and viability is essential to the success of any drug-discovery or drug-development campaign. Depending on the disease of interest, drug developers may seek to enhance cell repopulation (e.g., degenerative diseases) or inhibit it (e.g., cancers). Additionally, this is often the first step in characterizing new therapeutics, as assessment of candidate drugs for potential toxicity is critical before advancing into clinical trials.

Mitochondria play a fundamental role in maintaining overall cellular health by converting sugars and oxygen into energy (ATP), using a process that relies on their membrane potential. This is particularly true for neuronal cells due to their high energy demands and the apparent linkage between mitochondrial dysfunction and diseases such as Alzheimer’s disease, Parkinson’s disease, and ALS. Perturbations in mitochondrial function are detrimental to cell health and, therefore, are critical to monitor in any drug-development campaign, whether desirable (e.g., in cancer treatment) or not (e.g., off-target toxicity). Additionally, mitochondrial health is a valuable early indicator of drug toxicity which is, again, essential to address to ensure clinical success.

A multiplexed imaging approach can provide a more comprehensive view of cell and mitochondrial health, yet can be challenging to perform. Particularly, as cells senesce in vitro, they often detach from the growth surface, rendering accurate measurement of their viability and proliferation using standard antibody-based detection difficult or impossible due to potential cell loss exacerbated by the required pipetting and wash steps.

PhenoVista’s suite of Ready-2-Go cell and mitochondrial health assay services addresses this challenge via integration of streamlined, homogeneous, dye-based detection protocols into the assay workflow, ensuring the delivery of robust, reliable data and providing a comprehensive picture of cell health.

Ready-2-Go Assay Service

Cell Health

Robust, accurate, simultaneous analysis of cell viability, apoptosis, and proliferation using a homogeneous assay workflow with dye-based detection to ensure high-quality, comprehensive, cell-health assessment.
Ready-2-Go Assay Service

Mitochondrial Health

Precisely quantifies changes in mitochondrial membrane potential using a fluorescent dye whose accumulation is dependent upon mitochondria membrane potential, with parallel measurements of cell count and necrosis to deliver a more comprehensive picture of how drug treatment impacts overall cell health.
Ready-2-Go Assay Service

Neuronal Apoptosis & Cell Viability

Quantitative, robust, simultaneous analysis of neuronal cell viability and apoptosis that uses a physiologically relevant, iPSC-derived neuronal model with dye-based detection to ensure a high-quality, comprehensive assessment of neuronal health.
Ready-2-Go Assay Service

Neuronal Mitochondrial Health

Precisely quantifies changes in mitochondrial membrane potential in iPSC-derived neurons, using a fluorescent dye whose accumulation is dependent upon mitochondria membrane potential, with parallel measurements of cell count and necrosis to deliver a more comprehensive picture of how drug treatment impacts overall cell health.

Unique Questions. Unique Solutions.